ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment
Panic Disorder
About this trial
This is an interventional treatment trial for Panic Disorder focused on measuring panic disorder, proof of concept
Eligibility Criteria
Inclusion Criteria: Diagnosis of concurrent panic disorder At least 2 panic attacks within the 4 weeks before the screening visit Naïve to the CO2 challenge test Age 18-65 years (inclusive) Ability to comply with all procedures mandated by the study protocol Negative pregnancy test and adequate contraceptive measures Exclusion Criteria: History of poly-pharmacotherapy for panic disorder or treatment resistance Any current psychiatric Axis I DSM-IV diagnosis other than panic disorder, except concurrent simple phobia History of abuse of benzodiazepines or tolerance to effects of benzodiazepine Any concomitant psychotropic medication Evidence of impaired hepatic, renal or cardiac functions Participation in any drug trial in the preceding 6 months
Sites / Locations
- Charité - University Clinics Berlin
- Emovis, The institute of emotional health
- Academic Anxiety Center and Department of Psychiatry & Neuropsychology; Maastricht University